“The magnitude from the impact we noticed was about four moments larger than what clinical trials have shown for classic antidepressants on the market,” says Alan Davis, Ph.D., adjunct assistant professor of psychiatry and behavioral sciences at the Johns Hopkins College School of Drugs.